Tuesday, April 23, 2024 4/23/2024

Validation of Biomarkers of Pediatric TB and further development for use in diagnosis of childhood TB

Award Number: R01AI128765
ORGANIZATION: NATIONAL INSTITUTE OF ALLERGY & INFECTIOUS DISEASES
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

Group Awards By Issue Date FY or Funding FY:

View Award Abstract

Project summary / abstract The diagnosis of tuberculosis (TB) (both pulmonary and disseminated forms) in children is extremely difficult as current tests rely on culture of the causative bacteria from sputum or gastric aspirates. Culture of Mycobacterium tuberculosis may take several weeks and obtaining appropriate samples from young children is difficult. Even with the best available current methods a definitive diagnosis of childhood TB is only achieved in 20-30% of children clinically diagnosed as having TB. Lack of accurate and rapid diagnostic tests results in delayed treatment for many children, and conversely over-treatment of children who may not actually have TB is also common. There is thus an urgent need for improved diagnostic tests for childhood TB. As an alternative to detecting the causative Mycobacterium, identification of changes in blood proteins or the pattern of activation of genes in blood cells (protein or gene signatures or biomarkers) is a promising method for diagnosing many infections. The members of our consortium have previously studied well-characterised large groups of children with TB, and a range of other infections with similar symptoms to childhood TB. We have identified candidate protein and gene “signatures” which may be useful in the diagnosis of childhood TB. Our proposal is to take forward six promising protein and gene signatures (three based on proteins and three based on changes in expressed genes) for further validation in well established cohorts of children with suspected TB in four African countries which have high burdens of childhood TB (South Africa, Malawi, Kenya and The Gambia). Using available samples from over 4,000 well characterised child TB suspects, each of the six candidate biomarkers will be validated first using the same technology as used to detect the original biomarker and then using simpler technology which enables large numbers of patients to be analysed. In order to ensure that only the most accurate and reproducible biomarkers are taken forward, we will validate each biomarker in at least three different country cohorts. We will use sophisticated statistical methodology to select the most accurate biomarkers which can be taken forward for development as tests for clinical use. In order to translate promising biomarkers to clinical tests which can be applied even in resource poor settings we will use novel technology to detect the protein and gene signatures which will be validated as the basis of a diagnostic test.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2024 ( Subtotal = -$123,042 )
2024	2021	IMPERIAL COLLEGE OF SCIENCE, TECHNOLOGY AND MEDICINE	FACULTY BUILDING SOUTH KENSINGTON C	LONDON				GBR	Allergy and Infectious Diseases Research	000	5	10/23/2023	NON-COMPETING CONTINUATION	-$123,042
														Subtotal = -$123,042

Issue Date FY: 2021 ( Subtotal = $830,713 )
2021	2021	IMPERIAL COLLEGE OF SCIENCE, TECHNOLOGY AND MEDICINE	FACULTY BUILDING SOUTH KENSINGTON CAMPUS	LONDON				GBR	Allergy and Infectious Diseases Research	000	5	6/22/2021	NON-COMPETING CONTINUATION	$830,713
														Subtotal = $830,713

Issue Date FY: 2020 ( Subtotal = $1,095,861 )
2020	2020	IMPERIAL COLLEGE OF SCIENCE, TECHNOLOGY AND MEDICINE	EXHIBITION ROAD	LONDON		SW7 2AZ		GBR	Allergy and Infectious Diseases Research	000	4	11/25/2019	NON-COMPETING CONTINUATION	$1,095,861
														Subtotal = $1,095,861

Issue Date FY: 2019 ( Subtotal = $1,026,331 )
2019	2019	IMPERIAL COLLEGE OF SCIENCE, TECHNOLOGY AND MEDICINE	EXHIBITION ROAD	LONDON		SW7 2AZ		GBR	Allergy and Infectious Diseases Research	000	3	11/12/2018	NON-COMPETING CONTINUATION	$1,026,331
														Subtotal = $1,026,331

Issue Date FY: 2018 ( Subtotal = $1,000,208 )
2018	2018	IMPERIAL COLLEGE OF SCIENCE, TECHNOLOGY AND MEDICINE	EXHIBITION ROAD	LONDON		SW7 2AZ		GBR	Allergy and Infectious Diseases Research	000	2	11/22/2017	NON-COMPETING CONTINUATION	$1,000,208
														Subtotal = $1,000,208

Issue Date FY: 2017 ( Subtotal = $1,001,605 )
2017	2017	IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY & MEDICINE	EXHIBITION ROAD	LONDON		SW7 2AZ		GBR	Allergy and Infectious Diseases Research	000	1	12/13/2016	NEW	$1,001,605
														Subtotal = $1,001,605

Grand Total All Awards = $4,831,676

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Validation of Biomarkers of Pediatric TB and further development for use in diagnosis of childhood TB

Award Number: R01AI128765

ORGANIZATION: NATIONAL INSTITUTE OF ALLERGY & INFECTIOUS DISEASES

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer